G Bergamaschi

Subcutaneous erythropoietin for treatment of refractory anemia in hematologic disorders. Results of a phase I/II clinical trial.

G Barosi, M. Cazzola, E. Ascari, 1992, Blood.

Oligodeoxynucleotides antisense to c-abl specifically inhibit entry into S-phase of CD34+ hematopoietic cells and their differentiation to granulocyte-macrophage progenitors.

G Mazzini, M Cazzola, M. Cazzola, 1995, Blood.